Market Cap (In TWD)
10.03 Billion
Revenue (In TWD)
16.59 Million
Net Income (In TWD)
-817.31 Million
Avg. Volume
591.86 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.0-35.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- KYG0073G1091
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Sonny Hsiao Ph.D.
- Employee Count
- -
- Website
- https://www.acepodia.com
- Ipo Date
- 2023-08-08
- Details
- Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its unique antibody cell conjugation (ACC) platform technology to address gaps in cancer care. It links tumor targeting antibodies to its proprietary immune cells, such as gamma delta 2 T cells to create novel ACE therapies. The company was founded in 2017 and is headquartered in Grand Cayman, the Cayman Islands.
More Stocks
-
FITX
-
3807Fisco Ltd.
3807
-
002541
-
PROCProCook Group plc
PROC
-
NEXN
-
9962
-
BMBOY
-
KAIKadant Inc.
KAI